Mobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma Patients

Clinical trial NCT05087212 · COMPLETED

Trial details

NCT number: NCT05087212
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Autologous Haematopoietic Stem Cell Transplant

Start date: 2021-10-22
Primary completion: 2022-12-06
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.